Cargando…

Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes

Alcohol use disorder (AUD) is a highly prevalent health issue in the United States. The number of those receiving medication-assisted treatment (MAT) is limited, despite strong evidence for their effectiveness. The inpatient setting may represent an important opportunity to initiate MAT. The goal of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirchoff, Robert W., Mohammed, Norhan M., McHugh, Jack, Markota, Matej, Kingsley, Thomas, Leung, Jonathan, Burton, M. Caroline, Chaudhary, Rahul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105524/ https://www.ncbi.nlm.nih.gov/pubmed/33997645 http://dx.doi.org/10.1016/j.mayocpiqo.2021.01.013

Ejemplares similares

Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
por: Leung, Jonathan G., et al.
Publicado: (2022)

Naltrexone and the Treatment of Alcohol Dependence
por: Volpicelli, Joseph R., et al.
Publicado: (1994)

Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans
por: Leighty, Anne E., et al.
Publicado: (2019)

Naltrexone long-acting formulation in the treatment of alcohol dependence
por: Johnson, Bankole A
Publicado: (2007)

Views about responsibility for alcohol addiction and negative evaluations of naltrexone
por: Johnson, Rebecca A, et al.
Publicado: (2015)

Naltrexone ameliorates functional network abnormalities in alcohol‐dependent individuals
por: Morris, Laurel S., et al.
Publicado: (2017)

Use of Naltrexone in Internet Gaming Disorder
por: Gour, Rahul, et al.
Publicado: (2022)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Naltrexone-induced psychosis in a patient with alcohol use disorder
por: Ruei-Yuan, Hu, et al.
Publicado: (2023)

Remdesivir-induced conduction abnormalities: A molecular model-based explanation
por: Kingsley, Ryan, et al.
Publicado: (2023)

Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates
por: Terasaki, Dale, et al.
Publicado: (2022)

Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among Undergraduates
por: Leeman, Robert F, et al.
Publicado: (2013)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
por: Colquhoun, Ross M.
Publicado: (2013)

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
por: O'Kelly, Brendan, et al.
Publicado: (2022)

Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review
por: Ahmed, Rizwan, et al.
Publicado: (2018)

Medications and Patient Factors Associated With Increased Readmission for Alcohol-Related Diagnoses
por: Osborne, Joseph C., et al.
Publicado: (2021)

O-Benzoylnaltrexone
por: Yang, Rui, et al.
Publicado: (2013)

Asymmetric synthesis of (–)-naltrexone
por: Dongbang, Sun, et al.
Publicado: (2018)

Baclofen and naltrexone, but not N-acetylcysteine, affect voluntary alcohol drinking in rats regardless of individual levels of alcohol intake
por: Minnaard, A. Maryse, et al.
Publicado: (2020)

Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization
por: Chaudhary, Rahul, et al.
Publicado: (2020)

The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study
por: Ray, Lara A., et al.
Publicado: (2010)

Effectiveness of naltrexone treatment for alcohol use disorders in HIV: a systematic review
por: Farhadian, Negin, et al.
Publicado: (2020)

Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease
por: Ayyala, Divya, et al.
Publicado: (2022)

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
por: Terenius, Lars, et al.
Publicado: (2023)

Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder
por: Castaldelli-Maia, João M., et al.
Publicado: (2021)

Role of gut microbiota in cardiovascular diseases
por: Novakovic, Marko, et al.
Publicado: (2020)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

Naltrexone‐induced drug eruption
por: Heck, Johannes, et al.
Publicado: (2020)

Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
por: Galloway, Gantt P, et al.
Publicado: (2005)

Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats
por: Momeni, Shima, et al.
Publicado: (2015)

Effects of naltrexone on alcohol self‐administration and craving: meta‐analysis of human laboratory studies
por: Hendershot, Christian S., et al.
Publicado: (2016)

FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study
por: Bach, Patrick, et al.
Publicado: (2021)

Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
por: Szczesniak, Laura M., et al.
Publicado: (2020)

Safety of oral naltrexone in HIV-positive men who have sex with men and transgender women with alcohol use disorder and initiating antiretroviral therapy
por: Gonzales, Pedro, et al.
Publicado: (2020)

Commentary: Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats
por: Kalueff, Allan V.
Publicado: (2016)

Methylnaltrexone bromide methanol monosolvate
por: Li, Guoqing, et al.
Publicado: (2012)

Naltrexone: A History and Future Directions
por: Srivastava, A. Benjamin, et al.
Publicado: (2018)

Low-Dose Naltrexone in Rheumatological Diseases
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2023)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
por: Dahlberg, Sarah, et al.
Publicado: (2022)

Effect of combined naltrexone and bupropion therapy on the brain’s functional connectivity
por: Wang, Gene-Jack, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_spjhu2968j63g87umn29acasli